一种新的腺苷负荷心肌灌注心血管磁共振半定量评分系统的预后价值
研究纳入2009至2011年临床诊断或疑似冠心病的患者行腺苷负荷灌注心血管磁共振检查,基于负荷诱发灌注缺损、持续性、透壁性和负荷诱发收缩功能障碍计算缺血负荷评分,随访4年,主要终点为死亡、心力衰竭发作、急性冠脉综合征和室性心律失常的复合终点。128例中44例(34%)发生不良事件,灌注缺损持续存在的节段数对不良事件预测价值最强(OR 1.54;CI 1.19-2.00;p < 0.001)。作者结论认为该缺血负荷评分具有预后价值,灌注缺损持续存在对预后影响最大。
要点
- 灌注缺损持续存在的节段数是预测不良事件的最强指标(OR 1.54;CI 1.19-2.00;p < 0.001)。
- 负荷灌注阳性且发生不良事件者持续缺损节段数3.3 vs 无事件者1.3(p = 0.001)。
- 负荷灌注阳性且发生不良事件者最高评分19.6 vs 无事件者13.3(p = 0.012)。
核心结论
- 本研究提出的缺血负荷评分具有预后价值,灌注缺损持续存在对预后影响最大。
研究设计与样本
- 研究论文;2009至2011年纳入诊断或疑似冠心病患者128例,行腺苷负荷灌注心血管磁共振检查,计算基于负荷诱发灌注缺损、持续性、透壁性和负荷诱发收缩功能障碍的缺血负荷评分,随访截尾于4年,采用单因素和多因素逻辑回归分析。
关键影像表现/征象
- 负荷灌注阳性且发生不良事件者(n = 39)持续缺损节段数为3.3,高于负荷灌注阳性且无事件者(n = 28)的1.3(p = 0.001)。
- 负荷灌注阳性且发生不良事件者(n = 39)最高评分为19.6,高于负荷灌注阳性且无事件者(n = 28)的13.3(p = 0.012)。
诊断标准与关键数值
- 缺血负荷评分基于四项参数计算:负荷诱发灌注缺损、灌注缺损持续性、透壁性和负荷诱发收缩功能障碍。
- 持续缺损节段数预测不良事件的OR为1.54(CI 1.19-2.00;p < 0.001)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Cardiovascular magnetic resonance (CMR) provides information on myocardial ischemia through stress perfusion studies. In clinical practice, the grading of induced perfusion defects is performed by visual estimation of their extension. The aim of our study is to devise a score of the degree of ischemia and to test its prognostic value.
METHODS: Between 2009 and 2011, patients with diagnosed or suspected coronary artery disease underwent stress perfusion CMR. A score of ischemic burden was calculated on the basis of (1) stress-induced perfusion defect, (2) persistence, (3) transmurality, and (4) stress-induced contractile defect. Follow-up was censored after 4 years and primary end-point was defined by a composite of death, heart failure episode, acute coronary syndrome, and ventricular arrhythmias. Univariate and multivariate logistic regressions were used to assess the strength of the association between the CMR ischemic variables, and the composite outcome.
RESULTS: Forty-four of the 128 patients (34%) presented with adverse events, while 84 (66%) did not. Sixty-one patients (48%) had negative perfusion studies while 67 (52%) showed perfusion defect. Patients with positive perfusion studies and adverse events (n = 39) had higher number of segments with persistent defect (3.3 vs 1.3, p = 0.001) and highest score (19.6 vs 13.3 p = 0.012) than patients with positive perfusion studies and absence of events (n = 28). The number of segments with persistent defect showed the strongest predictive value of adverse events (OR 1.54; CI 1.19-2.00; p < 0.001).
CONCLUSIONS: The score of ischemic burden proposed herein has prognostic value. Persistence of a perfusion defect has the strongest impact on prognosis.
KEY POINTS: • Cardiovascular magnetic resonance provides information on myocardial ischemia by visual estimation of the presence of perfusion defects induced by stress. • There is not a standardized method for grading perfusion defects which, in practice, is performed by visual estimation of their extension. • As proven in this study, the integration of several parameters of perfusion defects (in addition to extension) into a semiquantitative score has prognostic value.
引用
- Gómez-Revelles S, Rossello X, Díaz-Villanueva J, et al. Prognostic value of a new semiquantitative score system for adenosine stress myocardial perfusion by CMR. Eur Radiol. 2018. PMID: 30406310. doi:10.1007/s00330-018-5774-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。